Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
University of Nebraska
Case Comprehensive Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Yale University
Case Comprehensive Cancer Center
Duke University
Mayo Clinic